In this 2019 paper, Crommelin et al. discuss the changing landscape of biologics and pharmaceutical formulation, analytical methods, immunogenicity and quality control. They specifically discuss the technology behind ParticleSentry and acknowledge the promise our approach demonstrates. The paper acknowledges the …